William Blair Equities Analysts Increase Earnings Estimates for Viking Therapeutics, Inc. (NASDAQ:VKTX)

Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – William Blair lifted their Q2 2024 earnings estimates for Viking Therapeutics in a research note issued to investors on Wednesday, April 24th. William Blair analyst A. Hsieh now anticipates that the biotechnology company will post earnings of ($0.17) per share for the quarter, up from their prior […]

Leave a Reply

Your email address will not be published.

Previous post Hasbro, Inc. to Post Q2 2024 Earnings of $0.61 Per Share, Roth Capital Forecasts (NASDAQ:HAS)
Next post Analysts Set EVgo, Inc. (NYSE:EVGO) PT at $5.19